All In MedTech

FDA Clearance Tracker · P830055-S270

LCS Total Knee System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 2, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 2, 2021

Approved

Time to decision

26 days

Received Jul 7, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830055-S270
Device name
LCS Total Knee System
Applicant
Depuy, Inc.
Applicant location
Warsaw, IN
Received
Jul 7, 2021
Decided
Aug 2, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830055

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Smithstown Light Engineering Ltd. Smithstown Ind Estate, Shannon, Co. Clare, Ireland V14 NW92 for manufacturing the ATTUNE Cementless RP Tibial Base component of the LCS® Total Knee System.

Source documents

Other decisions for Depuy, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.